EM1708G "Primary Biliary Cholangitis/Cirrhosis” (IM GR-081117)

To improve clinical management of patients with PBC
To show physicians and scientists how recent advances in our understanding of bile acid metabolism and inflammation may be relevant to the pathogenesis of PBC and may lead to new therapies

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

At the conclusion of this activity, the participant should be able to:

Recall the new name for primary biliary cirrhosis of “primary biliary cholangitis” and understand why the name was changed
Recognize the full spectrum of clinical presentation of PBC
Know the two FDA-approved therapies for PBC, and their mechanism of action

Course summary

Available credit:

Course opens:

08/16/2017

Course expires:

09/15/2017

Cost:

$0.00

Part of:

Photo: Marlyn J. Mayo, M.D. Marlyn J. Mayo, M.D.
Associate Professor of Medicine
Division of Digestive & Liver Diseases

Cost:

$0.00

Please login or create an account to take this course.

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome